Rivera-Hernández A, García-López A, Zurita-Cruz J

Language: Spanish
References: 18
Page: 168-174
PDF size: 360.59 Kb.

ABSTRACT

Introduction: some studies have shown an increase in the prevalence of obesity among children and adolescents, due to lifestyle changes during the COVID-19 pandemic. Objective: this study aims to identify the impact of social confinement due to COVID-19 on cardiovascular risk in adolescents with overweight or obesity. Material and methods: a retrospective cohort study was conducted with adolescents seen in a pediatric endocrinology clinic between 2019 and September 2022. Changes in biochemical profile, blood pressure, and anthropometry were assessed. Wilcoxon and Fisher's exact tests were used to compare the pre- and post-lockdown periods. Results: forty patients were included, with a median age of 11 years; 62.5% were male, and 60% had obesity. No significant changes were observed in z-score BMI or in blood pressure levels during follow-up. A reduction in blood glucose was observed, but there was an increase in total and LDL cholesterol, as well as in the proportion of patients with hypertriglyceridemia and metabolic syndrome. There was also an increase in cardiovascular risk, assessed by the Alustiza index. Conclusion: social confinement due to COVID-19 increased cardiometabolic risk factors in adolescents with overweight or obesity.

REFERENCES

1. Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023; 151(2): e2022060640. doi: 10.1542/peds.2022-060640. Erratum in: Pediatrics. 2024; 153(1): e2023064612. doi: 10.1542/peds.2023-064612.

2. Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025; 13(3): 221-262. doi: 10.1016/S2213-8587(24)00316-4. Epub 2025 Jan 14. Erratum in: Lancet Diabetes Endocrinol. 2025; 13(3): e6. doi: 10.1016/S2213-8587(25)00006-3.

3. Villasís-Keever MÁ, Zurita-Cruz J. El papel de los pediatras en el manejo de niños y adolescentes con sobrepeso u obesidad. Rev Mex Pediatr. 2023; 90(s1): s4-s9. doi: 10.35366/115874

4. Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genomics. 2020; 52(11): 549-557. doi: 10.1152/physiolgenomics.00089.2020

5. Kang HM, Jeong DC, Suh BK, Ahn MB. The impact of the coronavirus disease-2019 pandemic on childhood obesity and vitamin D status. J Korean Med Sci. 2021; 36(3): e21. doi: 10.3346/jkms.2021.36.e21

6. Gwag SH, Oh YR, Ha JW, Kang E, Nam HK, Lee Y et al. Weight changes of children in 1 year during COVID-19 pandemic. J Pediatr Endocrinol Metab. 2021; 35(3): 297-302. doi: 10.1515/jpem-2021-0554

7. Valenzise M, D'Amico F, Cucinotta U, Lugará C, Zirilli G, Zema A et al. The lockdown effects on a pediatric obese population in the COVID-19 era. Ital J Pediatr. 2021; 47(1): 209. doi: 10.1186/s13052-021-01142-0

8. Fleta-Zaragozano F, Moreno-Aznar L, Delgado-Peña YP, Bueno-Lozano M, Olivares-López JL. Concepto, clasificación y métodos de valoración del riesgo cardiovascular. Su importancia en pediatría. Bol Pediatr Arag Rioj Sor. 2008; 38(1): 17-24.

9. Arnaiz P, Pino F, Marín A, Barja S, Aglony M, Cassis B et al. Validación de un puntaje de riesgo cardiovascular en niños españoles aplicado a una población de escolares de Santiago de Chile. Rev Méd Chile. 2010; 138(10): 1226-1231.

10. La Fauci G, Montalti M, Di Valerio Z, Gori D, Salomoni MG, Salussolia A et al. Obesity and COVID-19 in children and adolescents: reciprocal detrimental influence-systematic literature review and meta-analysis. Int J Environ Res Public Health. 2022; 19(13): 7603.

11. Giannini C, Polidori N, Chiarelli F, Mohn A. The bad rainbow of COVID-19 time: effects on glucose metabolism in children and adolescents with obesity and overweight. Int J Obes (Lond). 2022; 46(9): 1694-1702.

12. Woo S, Yang H, Kim Y, Lim H, Song HJ, Park KH. Sedentary time and fast-food consumption associated with weight gain during COVID-19 lockdown in children and adolescents with overweight or obesity. J Korean Med Sci. 2022; 37(12): e103. doi: 10.3346/jkms.2022.37.e103.

13. Fernández JR, Redden DT, Pitrobelli AD. Waist circumference percentiles in nationally representative simples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004; 145(4): 439-444.

14. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003; 157(8): 821-827. doi: 10.1001/archpedi.157.8.821

15. Padilla-Rojas MM, Vilchis-Gil J, Zurita-Cruz J, Osorio-Alamillo Y, Huerta-Albarran R, Saltigeral-Simental P et al. Evaluación nutricional: diagnóstico de sobrepeso/obesidad y sus comorbilidades. Rev Mex Pediatr. 2023; 90(s1): s10-s17. doi: 10.35366/115875

16. Mondaca MI, Garrido SS, Orellana TR, Roa AM, Quezada CO, Osorio-Fuentealba C. COVID-19 lockdown effects on the anthropometrics, aerobic capacity, muscle function and metabolic control in children and adolescents with overweight and obesity. J Pediatr (Rio J). 2023; 99(5): 471-477. doi: 10.1016/j.jped.2023.03.008

17. Lin L, Burke J, Venkatesh S, Sadana P. AMPK-SIRT1-independent inhibition of ANGPTL3 gene expression is a potential lipid-lowering mechanism of metformin. J Pharm Pharmacol. 2019; 71(9): 1421-1428. doi: 10.1111/jphp.13138

18. Ghanemi A, Melouane A, Yoshioka M, St-Amand J. Exercise and high-fat diet in obesity: functional genomics perspectives of two energy homeostasis pillars. Genes (Basel). 2020; 11(8): 875. doi: 10.3390/genes11080875